Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

ROCKEFELLER UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

BATokines as Biomarkers of Brown Fat in Humans

Not Applicable

Active, not recruiting

Conditions: Healthy Lifestyle

Interventions: Other: Cooling Vest Procedure
Other: Fasting overnight

First Posted Date: 2021-09-20

Last Posted Date: 2025-05-14

Lead Sponsor: Rockefeller University

Target Recruit Count: 20

Registration Number: NCT05050240

Locations: 🇺🇸
The Rockefeller University Hospital, New York, New York, United States

Molecular Characteristics of Brodalumab in Hidradenitis Suppurativa

Early Phase 1

Completed

Conditions: Hidradenitis Suppurativa
Acne Inversa

Interventions: Drug: Brodalumab

First Posted Date: 2021-07-28

Last Posted Date: 2022-07-27

Lead Sponsor: Rockefeller University

Target Recruit Count: 4

Registration Number: NCT04979520

Locations: 🇺🇸
The Rockefeller University, New York, New York, United States

Time-Restricted Feeding

Not Applicable

Completed

Conditions: Inflammatory Markers
Ketosis
Glycemic Variation
Time Restricted Feeding
Obesity

Interventions: Other: Time restricted feeding arm
Other: usual feeding pattern arm

First Posted Date: 2021-05-13

Last Posted Date: 2022-08-24

Lead Sponsor: Rockefeller University

Target Recruit Count: 10

Registration Number: NCT04884659

Locations: 🇺🇸
The Rockefeller University Hospital, New York, New York, United States

RU Anti-SARS-CoV-2 (COVID-19) mAbs in Healthy Volunteers

Phase 1

Completed

Conditions: Covid19

Interventions: Biological: C144-LS and C-135-LS

First Posted Date: 2021-01-07

Last Posted Date: 2025-03-13

Lead Sponsor: Rockefeller University

Target Recruit Count: 23

Registration Number: NCT04700163

Locations: 🇺🇸
The Rockefeller University, New York, New York, United States

3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals

Phase 1

Completed

Conditions: Human Immunodeficiency Virus

Interventions: Drug: 3BNC117-LS
Drug: 10-1074-LS

First Posted Date: 2020-01-31

Last Posted Date: 2023-06-26

Lead Sponsor: Rockefeller University

Target Recruit Count: 6

Registration Number: NCT04250636

Locations: 🇺🇸
Weill Cornell Medical Center Clinical Trials Unit-CLOSED SITE, New York, New York, United States
🇺🇸
The Rockefeller University, New York, New York, United States
🇺🇸
Perelman School of Medicine University of Pennsylvania, Philadelphia, Pennsylvania, United States

An Alternative Dose Interval Study in Participants With Hidradenitis Suppurativa Receiving Brodalumab

Early Phase 1

Withdrawn

Conditions: Hidradenitis Suppurativa

Interventions: Drug: Brodalumab

First Posted Date: 2020-01-31

Last Posted Date: 2020-09-04

Lead Sponsor: Rockefeller University

Registration Number: NCT04249713

Locations: 🇺🇸
Rockefeller University Hospital, New York, New York, United States

When the Kidney Reacts to Nutritional Changes

Not Applicable

Completed

Conditions: Prehypertension

Interventions: Other: DASH

First Posted Date: 2019-10-29

Last Posted Date: 2021-08-05

Lead Sponsor: Rockefeller University

Target Recruit Count: 9

Registration Number: NCT04142138

Locations: 🇺🇸
The Rockefeller University, New York, New York, United States

Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.

Early Phase 1

Withdrawn

Conditions: Hidradenitis Suppurativa

Interventions: Drug: Guselkumab

First Posted Date: 2019-09-10

Last Posted Date: 2020-06-05

Lead Sponsor: Rockefeller University

Registration Number: NCT04084665

Locations: 🇺🇸
Rockefeller Unviersity, New York, New York, United States

A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin

Phase 1

Completed

Conditions: Cancer
Solid Tumor
Cancer of Skin

Interventions: Drug: 2141 V-11

First Posted Date: 2019-08-16

Last Posted Date: 2024-04-17

Lead Sponsor: Rockefeller University

Target Recruit Count: 16

Registration Number: NCT04059588

Locations: 🇺🇸
Rockefeller University, New York, New York, United States

DASH Diet Intervention at Senior Centers

Not Applicable

Completed

Conditions: Hypertension

Interventions: Behavioral: Revision of congregate meal menus and recipes to align with parameters of DASH eating plan
Behavioral: On-site blood pressure monitoring
Behavioral: Home self blood pressure monitoring
Behavioral: Medical adherence education
Behavioral: Nutrition Education

First Posted Date: 2019-06-21

Last Posted Date: 2020-12-09

Lead Sponsor: Rockefeller University

Target Recruit Count: 94

Registration Number: NCT03993808

Locations: 🇺🇸
Carter Burden Network Leonard Covello Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy